Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:54 AM
Ignite Modification Date:
2025-12-25 @ 3:54 AM
NCT ID:
NCT00134602
Eligibility Criteria:
Inclusion Criteria:
* Families with a child between the ages of 5 and 12 years old who is HIV-infected and who receives care at participating hospitals
* Informed consent for and assent from the child
* Informed consent for the primary caregiver (person responsible for most of the child's medication delivery) must be obtained. The parent/legal guardian must be able to give informed consent and willing to comply with protocol requirements.
* The HIV-infected child must be currently prescribed an antiretroviral therapy regimen.
Exclusion Criteria:
* The child or caregiver cannot respond to self-report questions because of cognitive impairments.
* The child receives home health care in which the home health care aide dispenses all of the child's medication (essentially resulting in directly observed therapy for that child).
* The child and/or the caretaker does not speak English or Spanish.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
12 Years
Study:
NCT00134602
Study Brief:
Protocol Section:
NCT00134602